Private · Company · Aksjeselskap

Thelper AS

922 432 244 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Oslo
ActiveRegistered 2019Similar companies →
Status
● Active
Founded
2019
Revenue
kr 1.08M
Operating result
kr -5.88M
↳ Brreg · companies
Operating at a lossFY2025 · -545% margin

Group financialsNOK

  • Revenue
  • Net profit
FY23FY24FY25
Revenue6.12M5.76M1.08M
Net profit-1.5M-5.88M
Regnskapsregisteret · company_revenue

Job ads on NAV Arbeidsplassen12 MO

No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months

Public contracts · won → est. expiryaward dates from Doffin/TED · hatched = our estimate, end dates aren't published

0 wins
Doffin/TED · company_tender_wins

Key figuresBrønnøysund

FY23FY24FY25TREND
Revenue6115k5760k1079k
Operating result-9622k-1436k-5877k
Net result-1500k-5884k
Regnskapsregisteret · company_revenue

MoneyNOK

Revenue
kr 1.08M
Operating result
−kr 5.88M
Net result
−kr 5.88M
Total assets
kr 5.71M
Equity
kr 4.79M
FY2025 kr 1.08M vs FY2024 kr 5.76M · -81% revenue
Regnskapsregisteret · company_financials · FY2025 (company)

Activitylast 24 mo

No job-ad activity on file
totals on file · ads-over-time series not yet in Intelligo
Registry changes
Accounts filed · sisteInnsendteAarsregnskap2024 → 20252026-07-02
NAV + JobStream · company_hiring · Brreg · company_changes

From the FY2025 accounts

FILEDAccounts filed for FY2025.
AUDITAudited by ERNST & YOUNG AS.
BALANCEEquity kr 4.79M.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose

Timelineall sources

accounts_filed: sisteInnsendteAarsregnskap2024 -> 2025Registry · 2026-07-02
Audit opinionErnst & Young AS issued an unmodified audit opinion on the 2025 financial statements. — gir arsregnskapet et rettvisende bilde av selskap...Annual report · 2025-12-31
Going concernThe board concludes that the going concern assumption is present and the accounts are prepared on that basis. — Pabakgrunnadettemenerstyr...Annual report · 2025-12-31
Going concernThe Brreg form answers 'no' to whether there is uncertainty about going concern. — Er det usikkerhet om fortsatt drift?: NeiAnnual report · 2025-12-31
Loan or financingPublic grants of NOK 16 million were awarded for ongoing development projects from 1 July 2025, partly not yet disbursed at the balance s...Annual report · 2025-12-31
Loan or financingThe company is working to raise further capital to finance continued development, but this is not considered a precondition for continued...Annual report · 2025-12-31
Related partyA shareholder loan of NOK 1 180 000 was granted on non-market terms (interest free) with no security provided. — Lanetergitt pavilkar som...Annual report · 2025-12-31
OwnershipThe lender is identified as the largest shareholder in Thelper AS. — (storste aksjonaer i Thelper AS).Annual report · 2025-12-31
Pledge or guaranteeNo loans or security have been given to senior employees, shareholders or others. — Det er ikke gitt|an eller sikkerhetsstilllse tiledend...Annual report · 2025-12-31
Staff numbersThe company employed 2.08 full-time equivalents during the financial year. — Antall arsverk i regnskapsaret: 2,08Annual report · 2025-12-31
RemunerationTotal payroll cost was NOK 2 001 626 against NOK 2 615 677 the prior year; no separate remuneration to daglig leder or board is disclosed...Annual report · 2025-12-31
Share capitalDuring the year cash contributions of NOK 10 080 684 were made, increasing share capital by NOK 41 665 to NOK 241 665. — Kontantinnskudd ...Annual report · 2025-12-31
ImpairmentIntangible assets with cost NOK 904 303 are fully depreciated/written down, leaving no carrying value at 31 December. — Samlede avskrivni...Annual report · 2025-12-31
OtherA SkatteFUNN project for targeted chemotherapy against aggressive tumours gave a tax deduction of NOK 1 161 844 for the year. — Skattefra...Annual report · 2025-12-31
OtherThe company is a biotechnology company aiming to develop innovative treatments against incurable cancers, based in Oslo. — Bioteknologise...Annual report · 2025-12-31
STARTUPLAB FOUNDERS FUND V AS acquired 6.0 pctNew owner · 2025-12-31
ALEAP FUND I AS acquired 5.2 pctNew owner · 2025-12-31
Skiwo · company_events

Tenders0 wins · 0 losses

No recorded tender wins.
Relevant open tenders — matched NACE 72.100 ↔ CPV
subscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-03

People4 roles

registered roles only · website-employee lookup awaits the crawler
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people

Structure

Owned by ↑ · top 4
STARTUPLAB FOUNDERS FUND V AS
6.0%
ALEAP FUND I AS
5.2%
LEISTEIN AS
2.5%
OSLO CANCER CLUSTER INCUBATOR AS
0.8%
Aksjonærregisteret · company_ownership · 2025 · both directions

LocationOslo

Oslo
municipality only · street address + coordinates not yet in Intelligo
Brreg · registered municipality
Is this your company? You can request removal here